CHRW Short Interest Jumps 33% in a Month as Earnings Land Today

C.H. Robinson Worldwide reports Q3 results today, October 28, with short interest at its highest level in six weeks and analysts having cut targets sharply in the run-up to the print.

Short sellers have been rebuilding positions aggressively. Short interest has risen 33% over the past month to 5.1% of the free float, climbing from roughly 4.6 million shares in late September to just over 6 million by October 27. The weekly move alone was 9.6%. That level is meaningful but not extreme, and the borrow market is nowhere near stressed: availability is deep at around 4,990%, meaning there are roughly 96 million shares available to lend against a short position of 6 million. Borrowing costs are low at 0.28%, down 30% on the week, so this is a conviction-driven increase in shorts, not a forced cover situation. Options positioning offers no further alarm: the put/call ratio of 0.31 sits almost exactly on its 20-day average, showing no particular rush for downside protection ahead of today's release.

The Street went into earnings with its pencils already worn down. JP Morgan cut its target from $225 to $198 on October 5, keeping its Overweight rating. Evercore ISI trimmed from $237 to $217 on October 6, also maintaining Outperform. BMO Capital went further on October 16, dropping its target from $190 to $160 while staying at Market Perform. The consensus mean price target now stands at $192, against a close of $143.59 on Tuesday, implying around 34% upside on paper. That gap is notable, but it reflects the scale of target cuts rather than fresh optimism: the direction of analyst travel over the past three weeks has been consistently lower. The analyst recommendation divergence factor ranks in the 92nd percentile, suggesting the spread of views is unusually wide. The dividend score ranks at 93, though the dividend history in the data runs only to mid-2022, so that figure should be treated with caution as a current income signal.

The RXO acquisition adds a structural dimension that earnings alone will not resolve. ORTEX forecasts an 84% probability that the deal triggers a share-count increase in the Russell 1000 and Russell 3000 indices, with estimated buying flows of $103 million and $713,000 respectively from index trackers. The MSCI World equivalent carries a 65% probability and around $100 million in estimated passive buying. All of these are forecasts tied to an expected announcement around June 2027, with dates described as estimated. The deal is the "why" behind the short interest build as well: investors are weighing how Robinson integrates a freight brokerage competitor in a weak freight environment, and the shorts appear to be betting the near-term execution risk outweighs the long-term scale story.

The last earnings release, on July 29, produced a 13.2% one-day decline, the only reaction reading in the data. The stock is down 2.4% over the past month heading into today, against a peer group that has generally held up better: UPS added 7.7% over the past week and Hub Group gained 5.3%, while CHRW managed only 2.1%. Expeditors International, the closest correlated peer, rose just 0.6% over the same period, so sector-wide selling is not entirely the explanation for CHRW's relative lag.

The short interest build of the past month, the analyst target cuts, and the memory of July's post-earnings drop all converge on today's Q3 release. The specific number to watch is gross margin on the NAST brokerage segment, where a recovery in spot rates would directly test the bear case around pricing power.